Buprenorphine/naloxone moves from Type 1 to Type 2 TPP drug
July 24, 2019
Change will be effective July 15, 2019.
Read more ➞
Change will be effective July 15, 2019.
Read more ➞
Check out our mobile-friendly, digital report for highlights of how ACP supported effective and safe pharmacy practice.
Read more ➞
Recent announcements serve as a good reminder to stay informed.
Read more ➞
Patient and prescriber information should never be shared on social media.
Read more ➞
Lessons Learned: Honesty, integrity, and record keeping are fundamental for dealings with third-party insurers.
Read more ➞
Third-year U of A student Dillon Lee earns ACP’s Leadership Development Award.
Read more ➞
The hearing decision involving Mohamed Elsayed Haggag is now available.
Read more ➞
Former pharmacist and patient safety officer Linda Poloway overwhelmed by prestigious award.
Read more ➞
Pharmacies can play a role in harm reduction.
Read more ➞
Licensees must ensure pharmacists and pharmacy technicians on staff are regulated.
Read more ➞